Back to results
US 2018/0215793 A1Published application
Virus-Like Particle
AssigneePharmaq AS
InventorsPal NILSEN, Marit RODE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.
Claims14
A recombinant piscine myocarditis virus (PMCV) virus-like particle (VLP) comprising a PMCV ORF1 protein.
Dependencies are inferred from the claim text.